Geoffrey Goodman Comments on Fallout from Crypto Lender Cred’s Bankruptcy
July 6, 2023
Fortune
Foley & Lardner LLP partner Geoffrey Goodman is quoted in the Fortune article, “Crypto lender Cred collapsed in 2020 after pulling in $135 million from customers. Its shady dealings foreshadowed FTX’s downfall—but regulators didn’t notice.”
Goodman, who co-chairs Foley’s Bankruptcy & Business Reorganization Practice Group, described Cred’s bankruptcy as a “hybrid” of multiple high-profile crypto bankruptcy cases.
“You had customers entrusting money to Cred that they believed was safe,” he explained, as Cred claimed to act like a “broker dealer or a Futures Commission merchant or a bank.” Instead, Goodman added, the money went in some cases to “unsavory charactors, [or] insiders absconding with [it].”
(Subscription required)
People
Related News
May 1, 2026
In the News
David Rosen Weighs in on SCOTUS Review of Skinny Label Patent Dispute
Foley & Lardner LLP partner David Rosen is featured across the media for his perspective on the U.S. Supreme Court case Hikma Pharmaceuticals v. Amarin Pharma.
April 27, 2026
In the News
Jesse Neil Featured as a Distinguished Leader in Law.com's Southeastern Legal Awards
Foley & Lardner LLP partner Jesse Neil is recognized in Law.com as one of the Distinguished Leader honorees for the 2026 Southeastern Legal Awards.
April 27, 2026
In the News
David Rosen and William Holtz Analyze FDA Approval Speed, Biotech Pressures
Foley & Lardner LLP attorneys David Rosen and William Holtz are quoted in the PharmaVoice article, “FDA’s need for speed could strain small biotechs. Here’s how they can keep up,” examining the FDA’s accelerated drug approval initiatives and its impact on smaller pharmaceutical companies.